The U.S. Food and Drug Administration has approved Lantidra, a cellular therapy medication used for the treatment of type 1 diabetes.
The FDA granted approval of Lantidra to Chicago-based biotech CellTrans Inc.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
by Joji Xavier
For comments and feedback: contact editorial@rttnews.com